ES521371A0 - Un procedimiento para la purificacion de un anticuerpo. - Google Patents

Un procedimiento para la purificacion de un anticuerpo.

Info

Publication number
ES521371A0
ES521371A0 ES521371A ES521371A ES521371A0 ES 521371 A0 ES521371 A0 ES 521371A0 ES 521371 A ES521371 A ES 521371A ES 521371 A ES521371 A ES 521371A ES 521371 A0 ES521371 A0 ES 521371A0
Authority
ES
Spain
Prior art keywords
antibody
purification
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES521371A
Other languages
English (en)
Spanish (es)
Other versions
ES8404858A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hybritech Inc
Original Assignee
Hybritech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hybritech Inc filed Critical Hybritech Inc
Publication of ES8404858A1 publication Critical patent/ES8404858A1/es
Publication of ES521371A0 publication Critical patent/ES521371A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C07K16/468—Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ES521371A 1982-04-12 1983-04-11 Un procedimiento para la purificacion de un anticuerpo. Granted ES521371A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36778182A 1982-04-12 1982-04-12

Publications (2)

Publication Number Publication Date
ES8404858A1 ES8404858A1 (es) 1984-05-16
ES521371A0 true ES521371A0 (es) 1984-05-16

Family

ID=23448565

Family Applications (3)

Application Number Title Priority Date Filing Date
ES521371A Granted ES521371A0 (es) 1982-04-12 1983-04-11 Un procedimiento para la purificacion de un anticuerpo.
ES528000A Granted ES528000A0 (es) 1982-04-12 1983-12-13 Un procedimiento para la purificacion de un antigeno.
ES528001A Expired ES8706964A1 (es) 1982-04-12 1983-12-13 Un procedimiento para fraccionar anticuerpos de suero.

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES528000A Granted ES528000A0 (es) 1982-04-12 1983-12-13 Un procedimiento para la purificacion de un antigeno.
ES528001A Expired ES8706964A1 (es) 1982-04-12 1983-12-13 Un procedimiento para fraccionar anticuerpos de suero.

Country Status (11)

Country Link
EP (1) EP0105359A4 (enExample)
AT (1) AT393386B (enExample)
AU (1) AU622099B2 (enExample)
CA (1) CA1209907A (enExample)
CH (1) CH672028A5 (enExample)
DK (1) DK192191A (enExample)
ES (3) ES521371A0 (enExample)
FI (1) FI88403C (enExample)
GB (1) GB2128630B (enExample)
IT (1) IT1219779B (enExample)
WO (1) WO1983003678A1 (enExample)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8328918D0 (en) * 1983-10-28 1983-11-30 Unilever Plc Alkaline phosphatase
GB8331071D0 (en) * 1983-11-22 1983-12-29 Karayiannis P Assay for dna/rna
US4666865A (en) * 1984-01-13 1987-05-19 Centocor, Inc. Immunoassay for biologically active human interferon-gamma employing unique monoclonal antibodies
US4789631A (en) * 1984-02-17 1988-12-06 Synbiotics Corporation Immunoassay for anti-dirofilaria immitis antibody
GB8426468D0 (en) * 1984-10-19 1984-11-28 Technology Licence Co Ltd Monoclonal antibodies
AU5259786A (en) * 1985-01-30 1986-08-07 United States Of America, The Monoclonal antibodies against chlamydial genes specific lipopolysaccharide
US4818687A (en) * 1985-02-28 1989-04-04 Massachusetts Institute Of Technology Affinity column and process for detection of low molecular weight toxic substances
US4859611A (en) * 1985-02-28 1989-08-22 Massachusetts Institute Of Technology Affinity column and process for detection of low molecular weight toxic substances
IL75828A (en) * 1985-07-17 1991-06-10 Univ Ramot Immobilization by biologically active proteins
NZ218336A (en) * 1985-12-09 1991-08-27 Kirin Amgen Inc Monoclonal antibodies to human pluripotent granulocyte colony stimulating factor (hpg-csf)
US5175255A (en) * 1987-03-23 1992-12-29 Amgen Inc. Methods for purification of platelet-derived growth factor
US5190859A (en) * 1987-02-26 1993-03-02 Dana-Farber Cancer Institute, Inc. Purification of LFA-3
SE468653B (sv) * 1987-03-06 1993-02-22 Perstorp Biolytica Adsorbent foer isokratisk affinitetskromatografi
JPS6463599A (en) * 1987-05-01 1989-03-09 Xoma Corp Purification of immunoglobulin by selective anti-idiotype bond
WO1989000695A1 (en) * 1987-07-14 1989-01-26 The Victoria University Of Manchester Method for the diagnosis of infections with detection of lipopolysaccharide antigens
CA1323567C (en) * 1987-10-05 1993-10-26 Gene R. Nathans Method for purification of antibodies
US5372812A (en) * 1988-04-04 1994-12-13 The General Hospital Corporation Composition and method for acceleration of clot lysis
US5582862A (en) 1988-04-04 1996-12-10 General Hospital Corporation Antibodies that bind to α2-antiplasmin crosslinked to fibrin which do not inhibit plasma α2-antiplasmin
CA2266341A1 (en) * 1996-09-20 1998-03-26 The General Hospital Corporation Composition and method for enhancing fibrinolysis using antibodies to alpha-2-antiplasmin
CA2721052C (en) * 2008-04-11 2023-02-21 Chugai Seiyaku Kabushiki Kaisha Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly
US20140234340A1 (en) 2010-11-30 2014-08-21 Chugai Seiyaku Kabushiki Kaisha Antigen-binding molecule capable of binding to plurality of antigen molecules repeatedly
BR112013021526B1 (pt) 2011-02-25 2021-09-21 Chugai Seiyaku Kabushiki Kaisha Polipeptídio variante, métodos para manter ou diminuir as atividades de ligação a fcgriia (tipo r) e fcgriia (tipo h) e aumentar a atividade de ligação a fcgriib de um polipeptídio e para a supressão da produção de um anticorpo contra um polipeptídio compreendendo a região fc do anticorpo, métodos para a produção do referido polipeptídio com atividades de ligação mantidas ou diminuídas e aumentada e para a produção suprimida de um anticorpo, composição farmacêutica e uso de um polipeptídio
WO2013047748A1 (ja) 2011-09-30 2013-04-04 中外製薬株式会社 複数の生理活性を有する抗原の消失を促進する抗原結合分子
CA2857159C (en) 2011-11-30 2024-05-07 Chugai Seiyaku Kabushiki Kaisha Drug containing carrier into cell for forming immune complex
RS62749B1 (sr) 2014-12-19 2022-01-31 Chugai Pharmaceutical Co Ltd Anti-c5 antitela i načini njihove upotrebe
NZ730607A (en) 2014-12-19 2022-07-01 Chugai Pharmaceutical Co Ltd Anti-myostatin antibodies, polypeptides containing variant fc regions, and methods of use
WO2017110981A1 (en) 2015-12-25 2017-06-29 Chugai Seiyaku Kabushiki Kaisha Anti-myostatin antibodies and methods of use
IL264626B (en) 2016-08-05 2022-07-01 Chugai Pharmaceutical Co Ltd Composition for prophylaxis or treatment of il-8 related diseases
EP3574010A4 (en) 2017-01-30 2020-12-16 Chugai Seiyaku Kabushiki Kaisha ANTI-SCLEROSTIN ANTIBODIES AND METHOD OF USE
CN110724204B (zh) * 2019-11-18 2021-10-22 广东菲鹏制药股份有限公司 Fc融合蛋白的纯化方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4172124A (en) * 1978-04-28 1979-10-23 The Wistar Institute Method of producing tumor antibodies
JPS58500127A (ja) * 1981-02-26 1983-01-20 ユニリ−バ−　ナ−ムロ−ゼ　ベンノ−トシヤ−プ 回収
US4474893A (en) * 1981-07-01 1984-10-02 The University of Texas System Cancer Center Recombinant monoclonal antibodies
US4361509A (en) * 1981-12-14 1982-11-30 Scripps Clinic And Research Foundation Ultrapurification of factor VIII using monoclonal antibodies

Also Published As

Publication number Publication date
AU622099B2 (en) 1992-04-02
CA1209907A (en) 1986-08-19
ES8506902A1 (es) 1985-08-01
ES8404858A1 (es) 1984-05-16
EP0105359A4 (en) 1984-08-20
FI88403C (fi) 1993-05-10
FI834530A0 (fi) 1983-12-09
AT393386B (de) 1991-10-10
EP0105359A1 (en) 1984-04-18
ES8706964A1 (es) 1987-07-01
GB2128630B (en) 1986-08-28
WO1983003678A1 (en) 1983-10-27
ES528000A0 (es) 1985-08-01
DK192191D0 (da) 1991-11-26
FI834530L (fi) 1983-12-09
ATA901983A (de) 1991-03-15
IT1219779B (it) 1990-05-24
ES528001A0 (es) 1987-07-01
GB8332644D0 (en) 1984-01-11
DK192191A (da) 1991-11-26
AU7256987A (en) 1987-09-03
FI88403B (fi) 1993-01-29
GB2128630A (en) 1984-05-02
CH672028A5 (enExample) 1989-10-13
IT8320550A0 (it) 1983-04-12

Similar Documents

Publication Publication Date Title
ES521371A0 (es) Un procedimiento para la purificacion de un anticuerpo.
ES528627A0 (es) Un procedimiento para la preparacion de pirazolo-y piridazo-pirazolinas,-piridazinas y-diazepinas.
ES523858A0 (es) Un procedimiento para la preparacion de benzotienil benzofuranil o naftil-derivados.
ES525175A0 (es) Procedimiento para la formacion de un compuesto elastico.
ES506969A0 (es) Un procedimiento para la preparacion de pirimidinas sustitu-idas.
ES501645A0 (es) Un procedimiento para la preparacion de 6-alquiliden-penamas.
ES505464A0 (es) Un procedimiento para la preparacion de n-heterociclilaminocarbonil arilsulfonamidas.
ES520730A0 (es) Un procedimiento para la prepracion de nuevas benzolactamas.
ES530418A0 (es) Un procedimiento para la preparacion de pirazolopiridinas.
ES503307A0 (es) Un procedimiento para la preparacion de quinoxaliniloxieteres.
ES515159A0 (es) Un procedimiento para la preparacion de 2-guanidino-4-heteroariltiazoles.
ES507506A0 (es) Un procedimiento para la pre-paracion de imidazolilfenilami-dinas.
ES521318A0 (es) Un procedimiento para la preparacion de compuestos de bencimidazol.
ES521984A0 (es) Un procedimiento para la produccion de ribavirina.
ES524346A0 (es) Procedimiento para la obtencion de poliaminas primarias.
ES522120A0 (es) Un procedimiento para la preparacion de 4-aril-4-piperidincarbinoles.
ES527780A0 (es) Un procedimiento para la preparacion de nuevas espiro-3-azolindionas.
ES507919A0 (es) Un procedimiento para la preparacion de benzopiranotriazoles antialergicos.
ES523136A0 (es) Un procedimiento para la preparacion de un compuesto.
ES514335A0 (es) Un procedimiento para la preparacion de guanidinas.
ES499936A0 (es) Un procedimiento para la purificacion de glucosaminoglucanos
ES506034A0 (es) Un procedimiento para la preparacion de n-carboxialquil-dipeptidos.
ES532777A0 (es) Un procedimiento para la preparacion de aricoxicicloalcanolaminolaminoalquilen-aril-cetonas.
ES520076A0 (es) Un procedimiento para la preparacion de pirropirroles.
ES520140A0 (es) Un procedimiento para la preparacion de acicloguanosina.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970401